Free Trial

Prenetics Global Limited (NASDAQ:PRE) Short Interest Update

Prenetics Global logo with Medical background

Prenetics Global Limited (NASDAQ:PRE - Get Free Report) was the recipient of a large drop in short interest in May. As of May 15th, there was short interest totalling 23,600 shares, a drop of 20.8% from the April 30th total of 29,800 shares. Currently, 0.3% of the company's shares are short sold. Based on an average daily volume of 15,900 shares, the days-to-cover ratio is currently 1.5 days.

Institutional Investors Weigh In On Prenetics Global

A hedge fund recently bought a new stake in Prenetics Global stock. Quinn Opportunity Partners LLC purchased a new stake in Prenetics Global Limited (NASDAQ:PRE - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 12,339 shares of the company's stock, valued at approximately $72,000. Quinn Opportunity Partners LLC owned approximately 0.10% of Prenetics Global as of its most recent filing with the SEC. Institutional investors own 25.01% of the company's stock.

Prenetics Global Stock Performance

PRE traded down $0.32 during trading on Thursday, reaching $8.69. The company had a trading volume of 6,348 shares, compared to its average volume of 19,404. The firm's 50-day simple moving average is $5.77 and its 200 day simple moving average is $5.35. The company has a market cap of $106.00 million, a price-to-earnings ratio of -2.18 and a beta of 0.17. Prenetics Global has a 12-month low of $3.09 and a 12-month high of $11.99.

About Prenetics Global

(Get Free Report)

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies.

Featured Stories

Should You Invest $1,000 in Prenetics Global Right Now?

Before you consider Prenetics Global, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Prenetics Global wasn't on the list.

While Prenetics Global currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA
This Unique Robotaxi Play Could Deliver 10X Returns

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines